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his study shows that L1-like adhesion (LAD-1), the
 
sole 
 
Caenorhabditis elegans
 
 homologue of the L1
family of neuronal adhesion molecules, is required
for proper development of the germline and the early em-
bryo and embryonic and gonadal morphogenesis. In addi-
tion, the ubiquitously expressed LAD-1, which binds to
ankyrin-G, colocalizes with the 
 
C. elegans
 
 ankyrin, UNC-
44, in multiple tissues at sites of cell–cell contact. Finally,
we show that LAD-1 is phosphorylated in a ﬁbroblast
growth factor receptor (FGFR) pathway-dependent manner
 
on a tyrosine residue in the highly conserved ankyrin-binding
motif, FIGQY, which was shown previously to abolish the
T
 
L1 family of cell adhesion molecule (L1CAM) binding to
 
ankyrin in cultured cells. Immunoﬂuorescence studies
revealed that FIGQY-tyrosine–phosphorylated LAD-1 does
not colocalize with nonphosphorylated LAD-1 or UNC-44
ankyrin but instead is localized to sites that undergo me-
chanical stress in polarized epithelia and axon–body wall
muscle junctions. These ﬁndings suggest a novel ankyrin-
independent role for LAD-1 related to FGFR signaling.
 
Taken together, these results indicate that L1CAMs consti-
tute a family of ubiquitous adhesion molecules, which
participate in tissue morphogenesis and maintaining tissue
integrity in metazoans.
 
Introduction
 
The L1 family of cell adhesion molecules (L1CAMs)*
includes L1, CHL1, NrCAM, NgCAM, and neurofascin
in vertebrates (for review see Brummendorf et al., 1998),
 
neuroglian in 
 
Drosophila melanogaster 
 
(Bieber et al., 1989),
and C18F3.2 in 
 
Caenorhabditis elegans
 
 (Hutter et al., 2000;
Teichmann and Chothia, 2000). These transmembrane pro-
teins participate in numerous functions during nervous sys-
tem development, including neurite growth and fascicula-
tion, and axon guidance (for review see Brummendorf et al.,
1998; Cohen et al., 1998; for review see Fransen et al.,
1998). Both L1 and NrCAM are also expressed in nonneu-
 
ronal tissues (for review see Kadmon et al., 1998; Wang et
al., 1998) with L1 implicated in kidney-branching morpho-
genesis (Debiec et al., 1998) and immune response–induced
remodeling of lymph node fibroblastic reticular matrix (Di
Sciullo et al., 1998).
The extracellular portion of L1CAMs mediates cell adhe-
 
sion via homotypic and heterotypic interactions to other
adhesion and extracellular matrix proteins (for review see
Hortsch, 1996). In contrast, the cytoplasmic tail mediates
linkage to the spectrin-actin cytoskeleton by its interaction
with ankyrins (Davis and Bennett, 1994). Ankyrins are a
family of cytoplasmic proteins that couple distinct integral
 
membrane proteins (including L1CAMs, Na
 
 
 
/K
 
 
 
 ATPase,
anion exchanger, and the voltage-gated Na
 
 
 
 channel) to the
spectrin-actin cytoskeleton (for review see Bennett and
Chen, 2001). L1CAMs collaborate with ankyrin in the es-
tablishment of specialized membrane domains such as axon
initial segments and the nodes of Ranvier in vertebrates (for
review see Bennett and Chen, 2001).
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The L1CAM ankyrin association is abolished by phos-
phorylation of the conserved tyrosine residue in the an-
kyrin-binding motif, EDGSFIGQY (FIGQY), situated in
the cytoplasmic tail (Garver et al., 1997; Tuvia et al., 1997).
Neurofascin engineered to contain a FIGQY tyrosine-to-his-
tidine (FIGQH) substitution mutation that was first identi-
fied in human L1, abolishes both FIGQY-tyrosine phos-
phorylation and ankyrin binding to neurofascin in cultured
cells, suggesting either or both events are important for L1
function (Zhang et al., 1998). L1CAMs have also been
linked to other signal transduction pathway molecules,
which include src (Ignelzi et al., 1994), the Eph kinase Cek5
(Zisch et al., 1997), the fibroblast growth factor receptor
(FGFR) (Saffell et al., 1997), and the mitogen-activated
pathway kinase (Schaefer et al., 1999).
This paper reports the characterization of the sole 
 
C. elegans
 
homologue of the L1CAM family, which we designated as
LAD-1 (for L1-like adhesion). We show that LAD-1 is local-
ized to the plasma membrane at sites of cell–cell contact in vir-
tually all cells and that LAD-1 plays a role in embryonic and
gonadal morphogenesis. We also demonstrate that the LAD-1
cytoplasmic tail, which contains the conserved ankyrin-bind-
ing motif, can bind mammalian ankyrin. Furthermore, we re-
veal that the 
 
C. elegans
 
 ankyrins, encoded by the 
 
unc-44
 
 gene
(Otsuka et al., 1995), exhibit expression and localization pat-
terns similar to that of LAD-1. Finally, this study presents in
vivo evidence for FGFR-dependent tyrosine phosphorylation
of LAD-1 in the conserved ankyrin-binding motif, FIGQY,
and localization of FIGQY-tyrosine–phosphorylated LAD-1
(LAD-IP) in a complementary pattern to that of ankyrin at
sites of mechanical stress. These results suggest alternate roles
for L1CAMs as either general cell adhesion molecules coupled
by ankyrins to the spectrin-actin skeleton or as mediators of
FGFR signaling at specialized cell junctions.
Figure 1. LAD-1 is the sole C. elegans 
homologue of the L1CAM family. (A) 
Intron-exon structure of LAD-1 (based 
on the cDNAs isolated). Blue boxes indi-
cate exons. The hatched box indicates 
the unique 5  coding region for the short 
cDNA isoform. Distinct 3  UTRs and 
poly A tails of the cDNAs are also 
shown. Note that the shorter cDNA 
isoform lacks exons 1–4. (B, i) Predicted 
amino acid sequence for the longer 
lad-1 cDNA. The italicized NH2 terminus 
sequence in maroon indicates a predicted 
signal sequence peptide (SignalP; http://
www.cbs.dtu.dk/services/SignalP). The 
ORF encodes the canonical L1CAM of 
six Ig domains (each Ig domain is 
flanked by red cysteines) followed by 
five fibronectin type III repeats. (Each 
repeat is flanked by a dark blue 5  histi-
dine or phenylalanine and a light blue 3  
tyrosine.) The transmembrane domain is 
bold and underlined, whereas the 
ankyrin-binding motif is highlighted in 
green. The last three amino acids 
marked in fuchsia are a consensus PDZ-
binding motif. (B, ii) The pink italicized 
letters outline the start of the predicted 
signal sequence peptide for the second 
lad-1 isoform. The pink italicized letters 
in B, i, completes this signal sequence 
peptide. The resulting cDNA encodes 
for a LAD-1 isoform, which lacks the 
first two Ig domains. The schematics for 
the two LAD-1 isoforms are shown in E. 
(C) A phylogenetic analysis of the 
L1CAM family members indicates LAD-1 
is not an ortholog of any one vertebrate 
L1CAM family member. (D) Chromo-
somal deficiencies stDf7 and stDf8 
remove the lad-1 gene located on 
chromosome IV, whereas deficiencies 
nDf41, eDf18, and eDf19 do not. 
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Results
 
lad-1 
 
is the sole 
 
C. elegans
 
 homologue of the 
vertebrate L1CAM family
 
The 
 
C. elegans
 
 genome contains a single gene homologous to
the vertebrate L1 family of neuronal adhesion molecules
(Hutter et al., 2000; Teichmann and Chothia, 2000) (Fig.
1, C and D). We isolated cDNAs encoding two LAD-1 iso-
forms by a combination of 5
 
 
 
 rapid amplification of cDNA
ends and screening of a 
 
C. elegans
 
 mixed stage cDNA library
(Fig. 1, A, B, and E). One isoform encodes an LAD-1 pro-
tein, which shares the canonical L1CAM structure (for re-
view see Hortsch, 1996) of six extracellular Ig domains
linked to five fibronectin type III repeats followed by a
transmembrane domain and a cytoplasmic tail, containing
the ankyrin-binding motif, FIGQY (Fig. 1 E). The second
isoform, a result of an alternative splicing event, encodes a
shorter LAD-1 protein that has a unique signal sequence
peptide and lacks the first two Ig domains (Fig. 1, B and E).
 
LAD-1 is localized to the plasma membrane at sites of 
cell–cell contact in all cells throughout development
 
Immunoblots of mixed stage worm lysates with an affinity
purified antibody generated against the LAD-1 cytoplasmic
tail detected a complex pattern of LAD-1 products with ap-
parent molecular weights of 200, 185, 120, and 65 kD. This
variety of LAD-1 products suggested a combination of alter-
native splicing, posttranslational cleavage, and differential
glycosylation events, modifications known to occur in the
L1CAM family (for review see Hortsch, 1996; Hassel et al.,
1997). The polypeptides ranging between 20 and 30 kD
that were also detected by immunoblots represent non–LAD-
1–related products, since they also reacted with 
 
125
 
I-labeled
protein A alone (Fig. 2, A, 
 
i
 
).
Specificity of this antibody for LAD-1 was established
using embryos lacking the 
 
lad-1
 
 gene. Arrested embryos
homozygous for the chromosomal deficiency 
 
stDf7
 
, which
removes the 
 
lad-1 
 
gene (Fig. 1 D), did not show immu-
noreactivity with the LAD-1 antibody (Fig. 2, 
 
iii
 
). Immu-
nostaining of the adherens junction protein, JAM-1, with
the control monoclonal antibody, MH27 (Francis and
Waterston, 1985; Raich et al., 1999) showed that these
embryos arrest after intestinal development. On the con-
trary, embryos homozygous for 
 
nDf41, 
 
a similar chromo-
somal deficiency, which removes a majority of the genes
deleted by 
 
stDf7
 
 but leaves the 
 
lad-1
 
 gene intact (Fig. 1
D), showed wild-type levels and localization of LAD-1
(Fig. 2, A, 
 
ii
 
).
LAD-1 visualized by immunofluorescence was expressed
in all cells throughout development (Fig. 2, B–I), starting at
the onset of embryogenesis with its expression increasing
dramatically during embryonic morphogenesis (Fig. 2 C, ar-
row and arrowhead). Similar to the vertebrate and 
 
Dro-
sophila
 
 L1CAMs, LAD-1 was highly expressed in the ner-
vous system. LAD-1 is localized to the plasma membrane of
the cell bodies (Fig. 2 G, long arrow) and axonal and den-
dritic processes (Fig. 2, C, D, and G, arrowhead) and in
nonneuronal tissues such as the pharynx (Fig. 2 G, short ar-
row), hypodermis (Fig. 2 D, short arrow), body wall muscles
(Fig. 2 F, short arrow), and the germline (Fig. 2 I).
 
LAD-1 was strikingly localized to the plasma membrane
at sites of cell–cell contact as early as just before the two-cell
stage (Fig. 2 B, arrow). Localized LAD-1 was not detected in
one-cell embryos, which lack sites of cellular contact (Fig. 2
B, arrowhead). LAD-1 localization at cellular contact sites
was especially evident in the nematode germline where
LAD-1 was present at sites of oocyte–oocyte contact (Fig. 2
I, arrowheads) and in the membranes between germline nu-
clei (Fig. 2 I, arrows).
 
LAD-1 recruits cytoplasmic ankyrin to the plasma 
membrane in cultured cells and colocalizes with UNC-44 
ankyrins in vivo at sites of cellular contact
 
L1CAMs interact with ankyrins via the FIGQY ankyrin-
binding motif located in their cytoplasmic tails (Garver et
al., 1997; Zhang et al., 1998), which is also present in LAD-1.
To determine if LAD-1 binds ankyrin, we performed a
binding/recruitment assay using human embryonic kidney
293 cell cultures (Fig. 3, A and B) as described (Zhang et al.,
1998). Green fluorescent protein (GFP)–tagged 270 kD rat
ankyrin
 
G
 
 transfected into 293 cells was primarily localized in
the cytoplasm (Fig. 3 A) (Zhang et al., 1998). Upon cotrans-
fection with a chimera construct comprised of the LAD-1
cytoplasmic tail fused to the entire rat neurofascin extracel-
lular and transmembrane domains, the cytoplasmic anky-
rin
 
G
 
–GFP redistributed to the plasma membrane, colocaliz-
ing with the neurofascin–LAD-1 chimeric protein (Fig. 3
B). This result showed that the LAD-1 cytoplasmic tail
could bind and recruit cytoplasmic mammalian ankyrin to
the plasma membrane.
The above result suggests that LAD-1 could participate in
vivo in localizing 
 
C. elegans
 
 UNC-44 ankyrin, which is 70%
identical in the membrane-binding domains to vertebrate
ankyrins (Otsuka et al., 1995). We therefore compared the
expression and localization patterns of UNC
 
-
 
44 to that of
LAD-1. UNC-44, visualized by immunofluorescence using
an UNC-44 polyclonal antisera (a gift from A. Otsuka, Illi-
nois State University, Normal, IL) was ubiquitously
 
 
 
ex-
pressed in the gastrulating embryo and in multiple adult tis-
sues (Fig. 3, C–F). Similarly, UNC-44 was detected at high
levels in the nervous system (Fig. 3, D and E, arrows) and in
nonneuronal tissues such as the pharynx (Fig. 3 F, short ar-
row), body wall muscles (Fig. 3 F, arrowheads), and the hy-
podermis (unpublished data). Similar to LAD-1, UNC-44
ankyrin was localized to the plasma membrane at sites of
cell–cell contact (Fig. 3, C–F). Interestingly, cytoplasmic
ankyrin could be detected in the intestinal primordium (Fig.
3 C, long arrows). Unlike 
 
lad-
 
1, unc
 
-44
 
 expression as deter-
mined with this antibody first occurred during gastrulation
after 
 
lad-1
 
 expression was first detected (Fig. 3 C). In addi-
tion, 
 
unc-44
 
 is not expressed in the germline, indicating ab-
sence of a maternally derived UNC-44 protein.
These data suggest that LAD-1 could act as a general re-
ceptor for UNC-44 ankyrin at the plasma membrane in
multiple tissues. Based on this hypothesis, mislocalization of
LAD-1 was not expected in the absence of UNC-44. In-
deed, in embryos homozygous for the chromosomal defi-
ciency 
 
nDf41
 
, which deletes 
 
unc-44
 
, LAD-1 levels, and lo-
calization were unaltered (Fig. 2, A, 
 
ii
 
). We were unable to 
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Figure 2.
 
LAD-1 is localized to the plasma membrane at sites of cell–cell contact in all cells throughout development.
 
 (A, 
 
i
 
) An immunoblot of 
total 
 
C. elegans
 
 lysates reveals four major LAD-1 polypeptides (200, 185, 120, and 65 kD) that were detected by a rabbit polyclonal antibody 
raised against the LAD-1 cytoplasmic domain (lane 2). The lower bands are not LAD-1 related, since they are also recognized by 
 
125
 
 I-labeled 
protein A (lane 3). (Lane 1) Coomassie blue staining of total 
 
C. elegans
 
 lysate. Equivalent lysate amounts. (
 
ii
 
) 
 
nDf41 
 
homozygous embryos, which 
contains the 
 
lad-1 
 
gene, show LAD-1 immunodetection (green) unlike 
 
stDf7
 
 homozygous embryos, which lack the 
 
lad-1
 
 gene; only control anti-
body staining of JAM-1 is seen in red (
 
iii
 
). B and C show immunodetection of LAD-1 in embryos. (B) LAD-1 is localized to sites of cell–cell con-
tact, including the partial plasma membrane of a developing two-cell staged embryo (arrow). A one-cell embryo, which lacks contact sites, does 
not show LAD-1 localization (arrowhead). (C) LAD-1 is found in the developing nervous system (arrow) with robust LAD-1 staining in the nerve 
ring, the major 
 
C. elegans
 
 neuropil (arrowhead). D and E show LAD-1 expression in multiple tissues in a larva and adult, respectively. LAD-1 is 
present in the nerve ring and ventral nerve cord (D, arrowhead) and in the hypodermis (skin cells) (D, arrows), the plasma membrane of body 
wall muscles (F, arrow), neuronal cell bodies (G, long arrow), dendrites (G, arrowhead), and the pharynx (G, short arrow). LAD-1 is also present 
in the syncytial germline where its localization at contact sites is maintained. A schematic of the 
 
C. elegans
 
 germline is shown in H: arrowheads 
point to oocytes and arrows point to germ nuclei. The cross section of the cylindrical gonad reveals a single layer of germ nuclei around a cyto- 
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Figure 3. The LAD-1 cytoplasmic tail binds and recruits mammalian ankyrin to the plasma membrane in cultured cells and similar to LAD-1 
UNC-44 ankyrin is localized to the plasma membrane at sites of cell–cell contact in multiple tissues in C. elegans. (A) Cytoplasmic localization of 
exogenous ankyrin in human embryonic kidney 293 cells transfected with murine GFP-tagged ankyrinG (Zhang et al., 1998). Upon cotransfection 
with a neurofascin–LAD-1 cytoplasmic tail chimera, cytoplasmic ankyrinG (green) is recruited to the plasma membrane, colocalizing with the 
L1CAM chimera (B, red). Immunofluorescence labeling of UNC-44 in multiple tissues in embryos as shown in C and D. The long arrows in C point 
to cytoplasmic ankyrin in the intestinal primordium. No unc-44 ankyrin expression is evident in early embryos as indicated by the short arrow, 
which shows a 12-cell staged embryo. The arrows in D and E point to strong unc-44 ankyrin expression in the nerve ring in the embryo and adult, 
respectively. In the adult (F), UNC-44 ankyrin is detected in the pharynx (short arrow), body wall muscles (small arrowhead), body wall muscle sar-
comeres (large arrowhead), and commissural axons (long arrow). Bars: (A and B) 5  m; (C and D) 10  m; (E and F) 50  m.
 
plasmic core with T-shaped membranes between each nucleus. In a grazing section of the germline shown in I, LAD-1 is localized at oocyte–oocyte 
contact (arrowhead) and only the vertical part of the T-shaped membrane, which divides two neighboring germline nuclei (arrows). The top of 
the T does not show LAD-1 localization. Bars: (A) 20 
 
 
 
m; (B–I) 25 
 
 
 
m.
 
Figure 2 (continued) 
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Figure 4. Phosphorylation of LAD-1 at the conserved tyrosine residue of the ankyrin-binding motif, FIGQY, occurs in vivo, and LAD-1P 
localizes to polarized sites in epithelial tissues. (A) Immunoblots of BSA-coupled LAD-1 peptides containing phosphorylated or nonphos-
phorylated FIGQY-tyrosine ( P and  P, respectively): i, LAD-1P antibody; ii, LAD-1NP antibody. (B) Immunoblots of total C. elegans 
lysates blotted with antibodies against the LAD-1 cytoplasmic tail (lane 2), LAD-1P (lane 4), LAD-1NP (lane 5), and 
125I-labeled protein A 
(lane 3). Lane 5 shows that the 185 and 65 kD LAD-1 polypeptides contain the FIGQY epitope; only the 185-kD product is phosphorylated 
(lane 4, arrow). Lane 1 shows a Coomassie blue–stained C. elegans lysate and relative molecular weight markers. (C) Control nDf41 
homozygous embryos, which contains the lad-1 gene, show LAD-1P (i) and LAD-1NP (ii) staining (green) unlike embryos homozygous for 
stDf7, which lacks the lad-1 gene; positive staining of JAM-1 is in red. (D) Preincubation of the LAD-1P antibody with the phosphorylated 
FIGQY peptide eliminated LAD-1P signal in stained animals; only JAM-1 immunostaining in red was detected (i). LAD-1P signal (green) is 
not displaced by preincubation of the LAD-1P antibody with the nonphosphorylated FIGQY peptide (ii). (E) Immunodetection of LAD-1P is 
localized in the pharynx and intestine (i, long and short arrow, respectively) and in the hypodermis (ii, arrow). LAD-1P (green) colocalized 
with JAM-1 (red) at the adherens junctions of hypodermal and intestinal cells. This colocalization is seen in the overlay panels as a yellow 
signal. Bar: (C and D) 10  m; (E) 20  m. C. elegans LAD-1 in cell migration and morphogenesis | Chen et al. 847
determine if UNC-44 localization was affected by the loss of
LAD-1, since stDf7 removes both unc-44 and lad-1.
LAD-1 is phosphorylated in vivo at the FIGQY-tyrosine 
residue of the ankyrin-binding motif
Neurofascin–ankyrin interactions are abolished in cultured
cells upon phosphorylation of the FIGQY-tyrosine residue
(Garver et al., 1997; Tuvia et al., 1997). We generated two
affinity purified peptide antibodies able to recognize the
LAD-1 FIGQY motif that was phosphorylated and nonphos-
phorylated on the tyrosine residue, respectively, to determine
whether this tyrosine phosphorylation occurred in vivo.
Both antibodies were specific against LAD-1, since no
LAD-1 immunofluorescence signal could be detected with ei-
ther antibody in arrested stDf7 homozygous embryos, which
lack the lad-1  gene (Fig. 4 C); only immunodetection of
JAM-1 by the control antibody, MH27, was seen. On the
other hand, embryos homozygous for the nDf41 deficiency,
which does not remove the lad-1 gene, showed wild- type lev-
els and localization of LAD-1. Moreover, the FIGQY se-
quence against which the antibodies were generated is not
duplicated in the C. elegans genome. Taken together, these re-
sults indicated that these two peptide antibodies are specific
for LAD-1. We next confirmed that the phosphorylated
FIGQY-tyrosine LAD-1 antibody was indeed phosphoty-
rosine specific. Preincubation of the antibody with the tyro-
sine-phosphorylated FIGQY peptide before addition to meth-
anol-fixed animals eliminated immunostaining but left the
JAM-1 signal by the control antibody, MH27, intact (Fig. 4,
D, i, red signal). On the contrary, preincubation of the anti-
body with the nonphosphorylated peptide did not eliminate
the phosphorylated LAD-1 signal (Fig. 4, D, ii, green signal).
The nonphosphorylated LAD-1 (LAD-1NP) antibody
recognized only the 185 and 65 kD LAD-1 polypeptides,
(Fig. 4 B, lane 5), whereas the phosphorylated FIGQY-tyro-
sine antibody recognized only the 185 kD LAD-1 product
(Fig. 4 B, lane 4). These results demonstrate that only the
185 and 65 kD LAD-1 products contain the ankyrin-bind-
ing motif, FIGQY, of which only the 185 kD LAD-1 prod-
uct was phosphorylated. The faintness of the 185-kD band
detected by the phosphorylated FIGQY-tyrosine antibody is
consistent with relatively low levels of phosphorylated LAD-1
levels in C. elegans (Fig. 4 E). In brief, LAD-1 is indeed
phosphorylated at the FIGQY-tyrosine residue in vivo, but
this site-specific phosphorylation occurs differentially, sug-
gesting distinct roles for the different LAD-1 products.
LAD-1 FIGQY-tyrosine phosphorylation is dependent 
on the FGFR pathway
We determined the tyrosine kinase pathway that was re-
sponsible for LAD-1 phosphorylation by screening the fol-
lowing tyrosine kinase-deficient or -null mutants for de-
creased levels of phosphorylated LAD-1 (LAD-1P): vab-1
(Eph receptor kinase; George et al., 1998), kin-8 (Ror ki-
nase; Koga et al., 1999), let-23 (EGFR; Aroian et al., 1990),
and egl-15 (FGFR; DeVore et al., 1995). By immunofluo-
rescence, LAD-1P levels were dramatically reduced only in
the egl-15–null background, whereas the other three kinase
mutant backgrounds showed wild-type levels (Fig. 5, A and
B). Expression levels and localization of nonphosphorylated
LAD-1 appeared unaltered in the egl-15–null background
(Fig. 5 C). This result indicates that LAD-1 FIGQY-tyro-
sine phosphorylation is dependent on the FGFR pathway
and provides further evidence for the antibody specificity
against phosphorylated FIGQY-tyrosine.
LAD-1P is localized in polarized epithelial tissues to 
sites distinct from LAD-1NP and ankyrin
LAD-1P (Fig. 4, green) by immunofluorescence is localized
to polarized epithelial tissues such as the intestine and the
pharynx (Fig. 4 E, i, short and long arrow, respectively), the
hypodermis (Fig. 4 E, ii, arrow), and the vulva and the rec-
tum (unpublished data). We compared the localization of
Figure 5. LAD-1 FIGQY-tyrosine phosphorylation requires the 
FGFR pathway. In egl-15(n1454) homozygous-null larvae (B), LAD-
1P levels (green) are dramatically reduced compared with similarly 
arrested let-23(sy17) homozygous-null larvae (A). JAM-1 immuno-
staining is red. Levels and localization of LAD-1NP are not 
affected in the egl-15 (n1454) homozygous animals (C). Bar, 10  m.848 The Journal of Cell Biology | Volume 154, 2001
LAD-1P to that of LAD-1NP and UNC-44 ankyrin in the
polarized epithelia, focusing on the pharynx (Fig. 6) and the
intestine (Fig. 7). The pharynx is a single-cell–thick epithe-
lial tube made of muscle and marginal cells, which are lo-
cated with triradiate symmetry surrounding the pharyngeal
lumen. The muscle and marginal cells are joined at the api-
ces of the lumen by tight junctions thus dividing the mem-
branes into apical and basal domains (Fig. 6 A, schematic).
The apical surface (outlined in green) faces the lumen and
secretes cuticle, whereas the basal surface is lined with basal
lamina (White, 1988). In Fig. 6, B–D, the red signal indi-
cates the staining pattern of JAM-1 at the adherens junc-
tions, whereas the green signal indicates the respective stain-
ing patterns of LAD-1P, LAD-1NP, and UNC-44. In the
pharynx, LAD-1P does not colocalize with JAM-1 (Fig. 6,
B, iii, long arrow) but rather appears to be present in the
pharyngeal apical surface (Fig. 6, B, ii, short arrows). How-
ever, because of the lack of apical pharyngeal markers further
experiments have to be performed to confirm apical localiza-
tion of LAD-1P. White dots were introduced to outline the
pharynx in Fig. 6, B, C, iii, and D, iii, where it is difficult to
discern the entire organ. On the other hand, LAD-1NP and
UNC-44 ankyrin, although also expressed in the pharynx
did not overlap with LAD-1P localization on the apical sur-
face (Fig. 6, C and D).
Intestinal cells are connected to each other by adherens
junctions, dividing the membranes into apical and basal do-
mains (White, 1988). In Fig. 7, JAM-1 detection is shown
in red, and LAD-1P, LAD-1NP, and UNC-44 detection is
shown in green with the arrow pointing to the intestinal ad-
herens junctions. In the intestine, LAD-1P was localized to
the adherens junction (Fig. 7 A) unlike UNC-44 and LAD-
1NP (Fig. 7, B and C), which were localized to the basolat-
eral domains (Moorthy et al., 2000). The distinct localiza-
tion of UNC-44 from LAD-1P in the pharynx and intestine
is consistent with findings that ankyrin binding to neurofas-
Figure 6. Localization of LAD-1P is complementary to that of LAD-1NP and UNC-44 ankyrin in the pharynx. (A) A schematic of the lateral 
view and cross-section of the pharynx. The pharynx has an anterior (1) and a posterior bulb (2). The cross-section shows the muscle cells 
(yellow and marked with “M”) and the marginal cells (pink). The lumen-facing apical surface is outlined in green and indicated by the green 
arrow. The adherens junctions are in red in the cross-section and indicated by short red arrows. LAD-1P localization (B) is compared with 
those of UNC-44 ankyrin (C) and LAD-1NP (D) in the pharynx. The long arrow points to the adherens junction and the short arrow (C) points 
to the apical surface, whereas arrowhead 1 indicates the pharyngeal anterior bulb and arrowhead 2 the posterior bulb. The white dots in B, 
i–iii, C, iii, and D, iii, outline the entire pharyngeal organ. LAD-1P (green) appears to be localized to the pharyngeal apical surface (short ar-
rows) outlined by the adherens junctions (red and long arrow) revealed by JAM-1 labeling. LAD-1NP and UNC-44 ankyrin does not colocal-
ize with LAD-1P. Bar, 10  m. C. elegans LAD-1 in cell migration and morphogenesis | Chen et al. 849
cin in cultured cells is abolished upon FIGQY-tyrosine
phosphorylation. Moreover, the complementary localiza-
tions of LAD-1P and LAD-1NP strongly suggest distinct
roles for LAD-1, depending on its phosphorylation state.
Phosphorylated LAD-1 is localized in regularly spaced 
puncta at axon–body wall muscle junctions
The major longitudinal axon tracts in C. elegans include the
ventral and dorsal nerve cords, which are flanked by the sub-
lateral axon tracts (Fig. 8 A, schematic) (White et al., 1986).
Sublateral axons grow along the body wall muscle basement
membrane unlike the ventral and dorsal nerve cord. Com-
missural axons, originating from either the dorsal or ventral
nerve cord, also grow along the body wall muscle basement
membrane when they cross the sublateral axons (White et
al., 1986).
LAD-1P was localized by immunofluorescence to regu-
larly spaced puncta along the sublateral tracts (Fig. 8, B and
C, arrow) and to the portion of commissural axons (Fig. 8, B
and C, arrowheads) that are in contact with body wall mus-
cles (Fig. 8 D, red outline). These puncta are not sites of
synapse, since very few if any synapses are located along the
sublateral nerve tracts and commissural axons overlaying the
body wall muscles (White et al., 1986). Moreover, coimmu-
nostaining for LAD-1P and the UNC-17 vesicular acetyl-
choline transporter (Duerr, J., and J.B. Rand, personal
communication) did not reveal any colocalization. We hy-
pothesize that these puncta are adhesion sites for mainte-
nance of proper axonal positioning along the body wall mus-
cle basement membrane.
The LAD-1 pathway functions in the general adhesion 
of cells in the early embryo and is involved in the 
embryonic and gonadal morphogenesis
To assess the functions of LAD-1, we initially performed
RNA-mediated interference on LAD-1 using standard meth-
ods (Fire et al., 1998). RNA-mediated interference did not
reduce LAD-1 levels and resulted in no obvious phenotype
(unpublished data). However, transgenic animals expressing
a putative dominant negative LAD-1 construct exhibit mul-
tiple defects that suggested LAD-1 roles in embryonic and
gonadal morphogenesis. Expressed under the native LAD-1
promoter, this construct comprises the first three Ig domains
that are secreted extracellularly. We hypothesize that the sec-
ond Ig domain in the transgene, which is required for verte-
brate L1 homophilic binding (Zhao et al., 1998; De Angelis
et al., 1999), binds the extracellular domains of the endoge-
nous LAD-1, consequently impeding endogenous LAD-1
function. Transgenic animals displayed normal levels and lo-
Figure 7. LAD-1P (A, green) is colocalized with JAM-1 (red) at intestinal adherens junctions but is distinct from UNC-44 ankyrin (B) and 
LAD-1NP (C) localization. Arrows in A–C point to the intestinal adherens junction. Bar, 20  m.850 The Journal of Cell Biology | Volume 154, 2001
calization of LAD-1 based on immunofluorescence (unpub-
lished data), indicating that the expressed construct did not
interfere with the regulation of endogenous lad-1 expression.
Evidence that the Ig domain transgene interferes specifi-
cally with the endogenous LAD-1 pathway is based on the
consideration that phenotypes conferred by dominant nega-
tive constructs are generally exacerbated by the reduction of
the endogenous product targeted by the construct. Indeed,
when the Ig domain transgene was crossed into hemizygous
lad-1 animals (see Materials and methods) essentially no
cross progeny carrying both the deficiency and the transgene
were identified. Instead, 83% of the transgenic cross prog-
eny were wildtype for endogenous lad-1, whereas the re-
maining 17% were undetermined because the animals were
either sterile or their development was prematurely arrested.
The lack of a significant number of transgenic hemizygous
Figure 8. LAD-1P is detected along the sublateral axons and commissural axons crossing the sublateral axons in a regularly spaced punctate 
pattern. (A) A schematic of the C. elegans nervous system with two major nerve cords (ventral and dorsal) and smaller sublateral axon tracts 
on either side of the body. Sublateral axons grow along the body wall muscle basement membrane unlike the dorsal and ventral nerve cords. 
LAD-1P is localized specifically to sublateral axons (B, arrow) and the part of the commissural axons in contact with body wall muscles (B, ar-
rowhead). A magnified portion of the axon tract shown in B highlights the regular punctate localization pattern of LAD-1P. (C and E) LAD-1P 
(green) is detected only in sublateral axons that overlay the body wall muscles (D, red, and E). The body wall muscle (red) is detected by 
MH24, a monoclonal antibody that recognizes vinculin. The arrow in C points to a sublateral axon tract, whereas the arrowhead points to the 
transversing commissural axon. Bars: (A) 50  m; (B) 5  m; (C) 20  m. C. elegans LAD-1 in cell migration and morphogenesis | Chen et al. 851
LAD-1 cross progeny indicates that the Ig domain construct
in combination with reduced levels of endogenous wild-type
LAD-1 induced lethality, arrested development, or sterility.
Dominant negative LAD-1 transgenic animals displayed
pleiotropic phenotypes. 57% of the transgenic animals were
variable abnormal (Vabs) (Fig. 9, A, i and ii), which indicates
morphogenic defects, 34% showed uncoordinated move-
ments and variable lethality, and 40% showed defects in go-
nadal morphogenesis. Striking defects in germline and early
embryonic development were also observed. In the wild-type
germline (Fig. 9, B, iv), embryos are situated close to the vulva
(mid-sized arrows), and the oocytes are lined up in the proxi-
mal gonad (short arrows), whereas meiotic germline nuclei are
located more distally (long arrows). Loss of contact between
oocytes was observed in these transgenic animals, resulting in
oocytes with altered shapes and sizes (Fig. 9, B, i and iii). In
addition, many germ cell nuclei were completely enclosed by
a membrane (Fig. 9, B, iii, long arrows), suggesting the pres-
ence of premature oocytes. Many dominant negative LAD-1
transgenic embryos also had cells with altered shapes and posi-
tions (Fig. 9, B, ii). In the early C. elegans embryos, the invari-
ant cell position is critical for proper embryogenesis, due to
cell–cell signaling (Schnabel and Priess, 1997). Because of the
apparent loss of cell contact in these transgenic embryos,
many of these embryos did not complete embryogenesis.
The transgenic animals also displayed abnormal gonad
morphology. The wild-type hermaphrodite gonad consists
of two U-shaped tubular arms that are formed by distal tip
cells (DTCs) located at the tip of each arm, which migrate
during larval development along a characteristic path that
originates at the ventral midbody (Fig. 10 A, schematic)
(Kimble and Ward, 1988). Fig. 10 C shows a mild defect
Figure 9. LAD-1 plays a role in embryonic morpho-
genesis and in germline and early embryo development. 
(A) Transgenic animals expressing a dominant nega-
tive form of LAD-1 display morphogenetic defects: 
anterior Vabs (i) and posterior Vabs (ii) (a, anterior; p, 
posterior). Wild-type animals are shown in iii and iv. 
(B) Apparent cell adhesion defects between oocytes 
result in mispositioned and misshapen oocytes, 
(i, arrows, and iii, short arrow). In addition, misplaced 
germ cells and immature-looking oocytes were 
detected (iii, long arrows). Apparent cell adhesion 
defects in early embryos result in misshapen cells and 
embryos, indicated by arrows in ii, that have yet to be 
laid through the vulva as designated by the arrowhead. 
The wild-type germline is displayed in iv, showing 
normal germline nuclei (long arrows), properly shaped 
and positioned oocytes (short arrows), and wild-type 
embryos (mid-sized arrows). Bar, 25  m.852 The Journal of Cell Biology | Volume 154, 2001
where the DTCs are positioned slightly posterior of the mid-
body, marked by the vulva (arrows indicate the ends of the
gonad arms). More severe defects are shown in Fig. 10, D–F,
where extra DTC turns were observed.
No changes in the levels and localization of either UNC-
44 or LAD-1P were detected by immunofluorescence in
dominant negative LAD-1 transgenic animals (unpublished
data). These results indicated that the level of interference
likely to occur extracellularly did not affect LAD-1 FIGQY-
tyrosine phosphorylation or intracellular UNC-44 binding
and localization. These results are consistent with recent
data showing that ankyrin recruitment to the plasma mem-
brane by vertebrate L1 is independent of L1 extracellular
homo- and heterophilic interactions (Needham et al., 2001).
Discussion
This study reveals that LAD-1, the sole C. elegans L1CAM
homologue, is ubiquitously expressed at sites of cell–cell con-
tact and is required for germline development and embry-
onic and gonadal morphogenesis. In addition, both LAD-1
and ankyrin, which are shown to interact, are localized at
sites of cellular contact in vivo. Moreover, tyrosine phos-
phorylation in the conserved ankyrin-binding motif FIGQY,
which abolishes binding of neurofascin to ankyrin in cul-
tured cells, does indeed occur in vivo in LAD-1. LAD-1P is
localized to epithelial and axon–body wall muscle junctions
and does not colocalize with either LAD-1NP or UNC-44
ankyrin, suggesting a novel ankyrin-independent pathway
Figure 10. LAD-1 is required for the 
gonad morphogenesis. (A) A cartoon 
(not to scale) of a wild-type U-shaped 
gonad in C. elegans. Below each panel 
(A–F) is a schematic of an animal 
opened dorsally and spread out, display-
ing the migration path of the DTCs as 
seen in the corresponding DIC micro-
graph. In wild-type animals (A and B), 
the gonad arms, led by a DTC on each 
arm, grow in opposite directions along 
the ventral length of the body. Each DTC 
makes the appropriate turns to meet the 
other at the middle of the body. DL, 
dorsal left; VL, ventral left; VR, ventral 
right; DR, dorsal right; red bar, vulva.
In C, one DTC migrated a little too far to 
meet the other DTC that did not migrate 
far enough. D–F show various gonadal 
morphogenesis defects due to abnormal 
cell adhesion and/or DTC migration. 
The green arrows in B–F indicate the 
DTC, the numbered arrowheads indicate 
the progression of the DTC migration, 
and the red arrowhead points to the 
vulva. Bar, 50  m. C. elegans LAD-1 in cell migration and morphogenesis | Chen et al. 853
for LAD-1. Finally, we show that this LAD-1 phosphoryla-
tion is dependent on the FGFR pathway. Our data, extrapo-
lated to vertebrates, indicates that L1CAMs constitute a fam-
ily of ubiquitous adhesion molecules, which participate in
tissue morphogenesis and maintaining tissue integrity.
L1CAMs have been viewed primarily as neuronal adhe-
sion molecules with few reports of nonneuronal expression
and roles of L1CAMs in both vertebrates and Drosophila
(Bieber et al., 1989; Debiec et al., 1998; for review see Kad-
mon et al., 1998; Wang et al., 1998). Our results suggest
that L1CAMs function in multiple cell types early in embry-
onic development. The variable lethality and notched head
phenotype displayed by the dominant negative LAD-1
transgenic animals are characteristic of mutants such as vab-1,
which have defects in epithelial cell migration and cell adhe-
sion (George et al., 1998). Likewise, the gonadal abnormali-
ties may be due to defects in DTC migration or cell adhe-
sion of gonadal arms to the body wall muscles or both.
Drosophila neuroglian is expressed also in multiple tissues
throughout development, and loss of neuroglian results in
embryonic lethality (Bieber et al., 1989). Although the basis
for lethality has not been determined, causes may include
defects in cell adhesion and/or cell migration.
Based on the similar cellular localization of the ubiquitous
LAD-1 and UNC-44 ankyrins in C. elegans and ability of
LAD-1 to recruit ankyrin to cell membranes, we hypothesize
that LAD-1, and by extrapolation vertebrate L1CAMs, can
act as general ankyrin “receptors.” Consistent with this idea is
the finding that loss of neuroglian results in decreased levels
of DANK2, the neuronal-specific ankyrin, in the Drosophila
peripheral and central nervous systems (Bouley et al., 2000).
In turn, ankyrins can cluster L1CAMs into microdomains
due to multiple binding sites for the neurofascin (for review
see Bennett and Chen, 2001); such clusters for L1CAMs
would result in strong intercellular adhesion. Indeed, loss of
ankyrin–neurofascin interaction results in reduced neurofas-
cin-induced intercellular adhesion in cultured cells (Tuvia et
al., 1997). Ankyrins are known to bind distinct tissue-specific
integral membrane proteins, such as the Na
 /K
  ATPase and
the voltage-gated Na
  channel and have nonoverlapping
binding sites to these proteins and neurofascin (for review see
Bennett and Chen, 2001). We predict that these proteins to-
gether with L1CAMs could act as tissue-specific ankyrin
coreceptors to form microdomains required for tissue mor-
phogenesis and function. Supporting this prediction is the
loss of neurofascin/NrCAM and Na
  channel coclustering at
axon initial segment and nodes of Ranvier in ankyrin-G–defi-
cient mice (for review see Bennett and Chen, 2001). By ex-
trapolation, likely coreceptors for UNC-44 include the Na
 /
K
  ATPase encoded by eat-6 (Davis et al., 1995) and the
UNC-5 netrin receptor, which interacts with unc-44 by ge-
netic criteria (Colavita and Culotti, 1998).
A physical link between the FGFR and L1 via their Ig do-
mains has been proposed (Doherty and Walsh, 1996; Saffell
et al., 1997). However, subsequent studies showed that this
cis interaction is unlikely due to structural hindrance of the
putative binding motif, AAPYW (for review see Kamiguchi
and Lemmon, 2000). More recently, genetic studies in
Drosophila suggest that both the EGF and FGF receptors are
downstream targets of neuroglian activity in growth cone
decisions during sensory axon guidance (Garcia-Alonso et
al., 2000). Our data indicates that LAD-1 is a substrate for
FGFR pathway activity with preliminary data indicating
that this LAD-1 phosphorylation occurs downstream of the
FGFR-activated RAS pathway.
LAD-1P is localized in a polarized fashion in epithelial
junctions and at axon–muscle junctions, which are sites
lacking UNC-44 ankyrin in C. elegans. A similar localization
of FIGQY-tyrosine–phosphorylated L1CAMs at epithelial
adherens and neuromuscular junctions is conserved in both
vertebrates and Drosophila (S. Jenkins, personal communica-
tion). egl-15 FGFR is not known to be present at adherens
junctions, and the ligand for the FGFR is not likely to be lo-
cally released in such a restricted manner. These consider-
ations suggest the possibility that LAD-1 is phosphorylated
elsewhere in the cell and transported to adherens junctions.
We hypothesize that FIGQY-tyrosine phosphorylation cre-
ates a binding site for as yet unidentified proteins that could
transport and localize LAD-1P to both epithelial and axon
muscle junctions, sites where ankyrin is absent. Candidate
proteins include PDZ proteins known for trafficking and lo-
calizing receptors to signaling pathways (Setou et al., 2000).
The cytoplasmic tail of LAD-1 and several L1CAMs end in
a consensus sequence for the PDZ-binding domain, and a
recent finding indicates that neurofascin associates with the
PDZ protein syntenin-1 (Koroll et al., 2001).
It is puzzling that LAD-1P, which does not bind ankyrin,
is highly localized to the axon muscle and adherens junc-
tions, sites that routinely experience mechanical stress, par-
ticularly since loss of ankyrin interaction leads to reduced
L1CAM-induced intercellular adhesion in cultured cells
(Tuvia et al., 1997). Proteins such as PDZ proteins, which
participate in a variety of scaffolding and cytoskeletal linkage
roles at epithelial and neuromuscular junctions (Dimitrakos
et al., 1999) could bind, cluster, and associate LAD-1P to
the actin cytoskeleton. Thus, LAD-1P could play a role in
maintaining the integrity of both epithelial and axon muscle
connections. Alternatively or additionally, LAD-1P may
play a signaling role at cellular junctions.
FIGQY-tyrosine phosphorylation of LAD-1 may also cre-
ate a binding site for as yet unidentified phosphotyrosine
adaptor proteins, which in turn could mediate coupling to
signaling pathways and cytoskeletal proteins such as microtu-
bules or actin filaments. Preliminary data indicates that the
microtubule-binding protein, doublecortin, binds FIGQY-
tyrosine–phosphorylated L1CAMs (Kizhatil, K., personal
communication). zyg-8 is the C. elegans doublecortin homo-
logue, which has roles in polarized division of the single-cell
embryo. It will be of interest to investigate the possible inter-
action between lad-1 and zyg-8.
Taken together, the work on L1CAMs performed in C.
elegans,  Drosophila, and vertebrates suggest an expanded
repertoire of roles for L1CAMs (Fig. 11). We propose that
unphosphorylated LICAMs function as both cell adhesion
molecules required for embryonic development and gen-
eral ankyrin receptors at sites of cell–cell contact. Ankyrin
reciprocally clusters L1CAMs and other ankyrin-associated
integral membrane proteins to form specialized micro-
domains, which are required for proper tissue function.
Additionally, microdomains of L1CAMs allow for strong854 The Journal of Cell Biology | Volume 154, 2001
intercellular adhesion. Thus L1CAMs may function to es-
tablish not only lateral membrane microdomains but also
transcellular complexes. When phosphorylated, L1CAMs
no longer associate with ankyrins and can interact with a
different set of molecules, establishing a novel ankyrin-inde-
pendent pathway related to FGFR signaling. These mole-
cules are likely to include those that transport and localize
phosphorylated L1CAMs to epithelial and axon muscle
junctions where they may function to maintain integrity of
those mechanically stressed sites. Phosphorylated L1CAMs
may also act as signaling molecules by interacting with
phosphotyrosine adaptor proteins, which in turn could
mediate coupling to signaling pathways and cytoskeletal
proteins. The roles of phosphorylated L1CAMs and the
identity of signals promoting L1CAM phosphorylation,
the kinase(s), and phosphatases involved, and the conse-
quences of phosphorylation beyond loss of ankyrin-bind-
ing remain to be resolved. C. elegans and Drosophila with
their potential for genetic analysis will provide powerful
model systems to approach these questions with important
implications for vertebrates.
Materials and methods
Reagents
DNA cDNA clone yk5b1 was from Y. Kohara (National Institute of Genet-
ics, Mishuma, Japan); C. elegans mixed stage lambda ZAP cDNA library
was from R. Barstead (Oklahoma Medical Research Foundation, Okla-
homa City, OK); all cosmids were from the Sanger Center; plasmids pRF4
and pPD95.75 were from A. Fire (Carnegie Institute of Washington, Balti-
more, MD); rat ankyrinG–GFP and neurofascin–HA constructs were from
Zhang et al., 1998; pEGFP-N1 was from CLONTECH.
Strains The following strains were sent from the Caenorhabditis Genet-
ics Center: RW1333, RW1324, DA768, CB3823, CB3824, PS1423, and
MT3460. 
Antibodies Rabbit antiserum AO280 against the AO49 UNC-44 ankyrin
regulatory domain (Otsuka et al., 1995) was provided by A. Otsuka, Illi-
nois State University; monoclonal antibody MH27 recognizing JAM-1 and
MH24 recognizing vinculin were from Francis and Waterston, 1985; mono-
clonal antibody 1403 recognizing UNC-17/VAChT was from J. Duerr and
J.B. Rand, personal communications. Secondary antibodies conjugated
with FITC and rhodamine were from Jackson ImmunoResearch Laborato-
ries, Inc. DAPI was from Sigma-Aldrich.
Sequence analysis
Sequence alignments and the resulting dendrogram were made using
MacVector V6.5.1 (Oxford Molecular Co.).
Constructs
lad-1–GFP dominant negative plasmid construct, pLC84 The plasmid pLC84
fuses GFP in parent vector pPD95.75 to 5 kb of upstream and 12 kb of ge-
nomic LAD-1 sequence downstream of the initiating ATG start site from
cosmid C18F3.
Neurofascin–LAD-1 chimera LAD-1 cytoplasmic tail was fused to the
previously constructed neurofascin cytoplasmic tail-deleted–HA construct
(Zhang et al., 1998).
LAD-1 antibodies
6991 antibody Rabbits were immunized with LAD-1 cytoplasmic tail ex-
pressed in bacteria in-frame with glutathione S-transferase in a pGEX vec-
tor (Amersham Pharmacia Biotech). Sera were preadsorbed over a glu-
tathione S-transferase column then affinity purified using an antigen fusion
protein column.
LAD-1P antibody (1163P) and LAD-1NP antibody (1162NP)  Rabbits  were
immunized with the peptide CTEDGSFIGQY
PVPQKS coupled to NEM-
KLH (Pierce Chemical Co). Sera were preadsorbed over a column contain-
ing the nonphosphorylated peptide.
1162NP Antibodies from one rabbit eluted from this nonphosphorylated
peptide column showed no cross-reaction with the phosphorylated pep-
tide. The breakthrough from the column of nonphosphorylated peptide
was then affinity purified using a phosphorylated peptide column. The fi-
nal antibody preparation (1163P) showed no cross-reaction with the non-
phosphorylated peptide.
Immunoblots
Adult animals were harvested, pelleted in 50 mM phosphate buffer, pH
7.5, containing protease inhibitors, 1 mM Na pervanadate, and 10 mM
NaF, and frozen in liquid nitrogen before being directly dissolved in boil-
ing SDS-PAGE buffer containing 40 mM DTT. Immunoblots were per-
formed with affinity purified antibodies and visualized with 
125I-labeled
protein A as described (Moorthy et al., 2000).
Immunofluorescence microscopy
Worms were fixed and stained for indirect immunofluorescence using
standard protocols and the freeze-crack methanol fixation method (Epstein
and Shakes, 1995). Primary antibodies were used at the following concen-
trations: 1:500 for 6991 LAD-1, 1:300 for 1163P and 1162NP LAD-1 and
UNC-44, 1:1,500 for MH27, and 1:250 for MH24. Immunofluorescent im-
ages were obtained using a ZEISS LSM 410 laser scanning microscope.
Live animal visualization using Nomarski optics
Animals were placed on a 2% agarose pad using 1% 1-phenoxy-2-propanol
in M9 buffer as anesthetic. The pad was gently sealed with a no. 1 coverslip.
Dominant negative LAD-1 transgenic animal characterization
Dominant negative LAD-1 transgenic animals were generated by standard
transgenic technique (Epstein and Shakes, 1995). Transgenic strains carry-
ing the extrachromosomal arrays (pLC84; pRF4) (see above) were selected
using the pRF4 (rol-6[su1006] roller) phenotype as a dominant selectable
marker. Transgenic hermaphrodites were cloned and their progeny ana-
lyzed and scored for various phenotypes.
To determine if the transgene acted in a dominant negative fashion, we
crossed stDf7 into the transgenic line in the following manner. Transgenic
roller males were crossed into the RW1324 strain (stDf7/fem-1[e1991]unc-
24[e138]unc-22[s12]). 53 F1 cross progeny rollers were cloned, and their
genotypes and phenotypes were analyzed.
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